ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00269880
Recruitment Status : Completed
First Posted : December 26, 2005
Last Update Posted : May 25, 2015
Sponsor:
Information provided by (Responsible Party):
Centocor, Inc.